What Chalver Laboratories does

Chalver Laboratories (legal name Laboratorios Chalver de Colombia S.A.S.) is a privately held Colombian pharmaceutical manufacturer founded in 1970 and headquartered in Bogotá. The company develops, manufactures, and commercializes branded generic medications for human and veterinary use across four product lines: Primary Care, Institutional/Hospital, OTC, and Veterinary. Its 20,000 square meter production plant in Bogotá is INVIMA-certified (BPM/Good Manufacturing Practices) and was selected as a model plant for an OPS (Pan American Health Organization) inspection; the plant operates automated high-volume equipment with batch capacities up to 5,600 liters for liquids and 1,200 kg for solids, and includes the only facilities in Colombia specialized in metered-dose inhaler manufacturing and hormonal medication production.

The company monetizes through two principal channels: (1) direct sales of its branded pharmaceutical portfolio (including Multidol®, Fluturan®, Tibonella®, Estermax®, Inlabon®, Airmax®, and others spanning analgesics, women's health, respiratory, dermatology, ophthalmology, and intrahospital therapeutics) via its own field sales force and through major regional pharmacy chains, and (2) maquila contract manufacturing services for hormonal, veterinary, and human-use pharmaceutical products, plus lithographic printing and pharmacovigilance services as adjacent revenue streams.

Chalver operates wholly-owned administrative subsidiaries with direct sales infrastructure in 8 countries across South America, Central America, and the Caribbean (Colombia, Ecuador, El Salvador, Honduras, Panama, Dominican Republic, Nicaragua, Guatemala, and Aruba/Curacao), promoting its portfolio to more than 10 medical specialties in both private and institutional channels. No public listing, parent company, or external funding is disclosed; the company is privately held with no venture capital or private equity investment identified in the source material.

Name

Chalver Laboratories

Legal name

Laboratorios Chalver de Colombia S.A.S.

Website

https://chalver.com

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)

Keywords

• Pharmaceutical manufacturing
• Human medications
• Veterinary pharmaceuticals
• Contract manufacturing services
• Metered-dose inhalers

Headquarters

HQ city

Bogotá

HQ country

Colombia

HQ region

Latin America

Offices11 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Development, manufacturing, and commercialization of human and veterinary pharmaceutical products including OTC, institutional, primary care, and specialty medications. Products are promoted to more than 10 medical specialties through direct sales force.
2. Contract Manufacturing (Maquila) Services: Provides contract manufacturing services for hormonal products, veterinary products, and human-use products. Services include formulation, packaging, and quality control for third-party clients.
3. Lithography and Printing Services: Provides lithographic printing services including sheet and quarter-sheet formats (6, 4, and 2 colors), die-cutting, automatic gluing, laminating, CTP plate making, digital printing, flexography, and special finishes.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

Laboratorios Chalver de Colombia S.A.S. develops, manufactures, and commercializes human and veterinary pharmaceutical products across primary care, institutional, OTC, and specialty lines, operating a 20,000 sqm INVIMA-certified production plant in Bogotá. In parallel, the company offers contract manufacturing (maquila) services for hormonal, veterinary, and human-use pharmaceuticals, plus lithographic printing services, distributing its branded portfolio across 8 Latin American and Caribbean countries through its own field sales force and retail pharmacy chains.

Product overview

Chalver Laboratories is a Colombian pharmaceutical company with 53 years of experience manufacturing and commercializing human and veterinary medications. The company operates a 20,000 square meter production plant in Bogotá and offers a diversified portfolio organized into therapeutic categories: OTC health products (analgesics, cold/flu, probiotics), Women's Health (hormone replacement, vaginal treatments), Neuromuscular & Joint Health (B-complex vitamins, corticosteroids, anti-inflammatories), Digestive Health (laxatives, antiparasitics), Respiratory Health (inhalers for asthma/COPD), Skin Health (topical corticosteroids, antifungals), Eye Health (antibiotic/anti-inflammatory ophthalmic solutions), and Intrahospital Products (hormonal injections, anticoagulants, sedatives). Beyond its branded pharmaceutical portfolio, Chalver provides contract manufacturing services (maquila) for hormonal products, veterinary products, and human-use pharmaceuticals, plus lithographic printing services. The company operates across 8 countries in South America, Central America, and the Caribbean with headquarters in Bogotá, Colombia.

Differentiator

Problem solved

Functional benefit

Brands

• Hormonal Products Manufacturing: The only plant in Colombia for the development and manufacture of hormonal medications for human use, including contraceptives and menopause treatments
• Litography Services
• Veterinary Products Manufacturing

Products and services

• Multidol®

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Aspen Pharmacare: South African-headquartered specialty pharmaceutical company with international manufacturing and distribution across emerging markets. Comparable to Chalver as an emerging-market pharma operator with contract manufacturing capabilities and focus on women's health and specialty categories.
• Glenmark Pharmaceuticals: India-based pharmaceutical manufacturer with growing Latin American presence in dermatology, respiratory, and women's health. Comparable as an emerging-market manufacturer competing with Chalver in similar therapeutic categories and regional markets.

Direct peers

• Lafrancol: Colombian pharmaceutical laboratory operating across multiple therapeutic categories with a Latin American commercial footprint. Directly comparable to Chalver as a fellow Colombian pharma manufacturer competing in the same retail and institutional channels.
• Cifarma: Colombian pharmaceutical laboratory with broad therapeutic categories and Latin American presence. Directly comparable to Chalver in product mix, Colombian origin, and multi-country distribution.
• Procaps: Colombian pharmaceutical company with softgel and sterile manufacturing capabilities and Latin American distribution. Comparable to Chalver in pharma contract manufacturing (maquila), softgel expertise, and regional go-to-market model.
• Genfar: Colombian-affiliated generic and branded pharmaceutical manufacturer with regional Latin American distribution. Comparable to Chalver in therapeutic breadth, OTC/generic positioning, and multi-country presence in the Andean and Central American markets.
• Tecnoquímicas: Colombian pharmaceutical manufacturer with a similar multi-country Latin American footprint and broad therapeutic portfolio spanning OTC, prescription, and institutional products. Directly comparable in terms of being a regionally diversified Colombian pharma brand competing in primary care and institutional channels.

Broad incumbents

• Bayer: Global pharmaceutical incumbent with established Latin American commercial operations across OTC, women's health, and respiratory categories. Comparable as a broad incumbent competing with Chalver in therapeutic areas like hormone therapy and OTC analgesics.
• Eurofarma: Brazilian-headquartered multinational pharmaceutical company with the broadest Latin American footprint. Comparable as a larger incumbent regional pharma competitor that overlaps with Chalver in OTC, prescription, and contract manufacturing across Latin American markets.

Regional players

• Megalabs: Uruguay-headquartered pharmaceutical company with strong Latin American presence across multiple therapeutic areas. Comparable to Chalver as a Latin American regional pharma player with overlapping product portfolio and similar go-to-market strategy in primary care and OTC.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/ChalverEcuador
• Facebookfacebook.com/Chalverlaboratorios

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chalver Laboratories